Spatial repression of PCNA by p53 during kidney development

American Journal of Physiology - Renal Physiology

Volumn 283, Issue 4 52-4, 2002, Pages

  Saifudeen, Zubaida ^a   Marks, Jessica ^a   Du, Hong ^a   El Dahr, Samir S ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cell cycle; Gene transcription; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; PROTEIN P53;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE INACTIVATION; GENE REPRESSION; HUMAN; HUMAN CELL; KIDNEY DEVELOPMENT; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; TISSUE DISTRIBUTION;

EID: 0036783559     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00114.2002     Document Type: Article

References (46)

1. Maintenance of genomic integrity by p53: Complementary roles for activated and non-activated p53
2. Involvement of p53 in cell differentiation and development
3. Regulation of p53 stability
4. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta
5. p53 is a general repressor of RNA polymerase III transcription
6. UV inducibility of rat proliferating cell nuclear antigen gene promoter
7. p53 in embryonic development: Maintaining a fine balance
8. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression
9. Ontogeny of bradykinin B2 receptors in the rat kidney: Implications for segmental nephron maturation
10. Definition of a consensus binding site for p53
11. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein
12. A transcriptionally active DNA-binding site for human p53 protein complexes
13. Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys
14. Morphogen gradient interpretation
15. p53 gene is up-regulated during skeletal muscle cell differentiation
16. Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos
17. Tumor spectrum analysis in p53-mutant mice
18. Transcriptional regulation of the PCNA promoter by p53
19. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin
20. Transcriptional repression by p53 through direct binding to a novel DNA element
21. p53: Puzzle and paradigm
22. Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle
23. Regulation of p53 in response to DNA damage
24. p53-Mediated repression of alpha-fetoprotein gene expression by specific DNA binding
25. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression
26. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53
27. Regulation of proliferating cell nuclear antigen during the cell cycle
28. Analysis of the proliferating cell nuclear antigen promoter and its response to adenovirus early region 1
29. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin 3a
30. Analysis of the 5′ flanking region of the rat proliferating cell nuclear antigen (PCNA) gene
31. Regulation of the p53 tumor suppressor protein
32. Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter
33. Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease
34. Identification of novel Pax-2 binding sites by chromatin precipitation
35. Repression of Pax-2 by WT1 during normal kidney development
36. Regulation and function of the p53 tumor suppressor protein
37. A role for p53 in terminal epithelial cell differentiation
38. The bradykinin type 2 receptor is a target for p53-mediated transcriptional activation
39. Expression of p53 during mouse embryogenesis
40. Spatial specification of mammalian eye territories by reciprocal transcriptional repression of Pax2 and Pax6
41. Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter
42. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model
43. Interference with p53 protein inhibits hematopoietic and muscle differentiation
44. p53: Death star
45. The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations
46. Differential effect of p53 on the promoters of mouse DNA polymerase beta gene and proliferating-cell-nuclear-antigen gene